Approval · Notice of Compliance 7785 · 2006
REBIF: Notice of Compliance 7785
Issued February 27, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7785
- Date
- February 27, 2006
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing site and new fill volume
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REBIF | Not yet assigned | — |
| REBIF | 02277492 | Cancelled Post Market |
| REBIF (INITIATION PACK) | 02281708 | Cancelled Post Market |
Medicinal ingredients
- INTERFERON BETA-1A 8.8 MCG per 0.2ML
- INTERFERON BETA-1A 22 MCG per 0.5ML
- INTERFERON BETA-1A 44 MCG per 0.5ML